Skip to main content

Want a detailed portfolio tracker?

Performance analysis of BioNexus Gene Lab (BGLC)

Annual Return

Over the past 3 years, BGLC has had an average annual return of -70.02%, underperforming the benchmark SPY, which returned +19.31% annual.

Over the past 5 years, BGLC has had an average annual return of -62.16%, underperforming the benchmark SPY, which returned +12.55% annual.

Since Sep 16, 2020, BGLC has had an average annual return of -44.25%, underperforming the benchmark SPY, which returned +15.99% annual.

2026202520242023202220212020
-59.03%+41.37%-47.26%-95.35%-55.40%-7.39%+460.98%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026-34.25%+4.92%-21.48%-1.84%+10.54%-16.10%-16.92%-59.03%
2025+45.77%-19.57%-27.93%+20.62%+50.60%-28.44%+125.80%-18.10%-3.64%-0.90%-16.24%-13.00%+41.37%
2024-11.42%+21.28%+24.03%-12.20%-31.51%+11.94%+2.59%-9.59%+0.89%-19.03%-35.79%+20.85%-47.26%
2023+5.26%-48.50%+4.83%-39.16%-12.33%-23.26%-15.90%-23.32%-49.14%-51.81%+126.64%-44.23%-95.35%
2022-23.47%+15.95%-9.53%-4.09%-27.44%-4.20%-17.54%+23.40%-8.62%-3.78%+2.94%-9.52%-55.40%
2021+0%-8.70%-0%-5.24%-39.70%-4.16%+0.87%+27.59%-20.27%+60.17%-10.05%+25.29%-7.39%
2020+265.85%+66.67%+10%-16.36%+460.98%

Drawdown analysis of BioNexus Gene Lab (BGLC)

The maximum drawdown for the BGLC was -99.51%, occurring on Jul 20, 2026. This drawdown has not yet recovered.

The current BGLC drawdown is -99.51%.

Since Sep 16, 2020 BGLC has experienced the following drawdowns:

  • 50% or more: 2 times
  • 40% or more: 2 times
  • 30% or more: 2 times
  • 20% or more: 2 times
  • 10% or more: 3 times
DepthStartTo BottomBottomTo RecoverEndTotal
-99.51%Nov 2, 20201431Jul 20, 2026OngoingOngoingOngoing
-60.00%Sep 17, 20201Sep 18, 202027Oct 27, 202028
-17.26%Oct 27, 20201Oct 28, 20203Nov 2, 20204